Market Overview
Global Pharmaceutical Glass Packaging Market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030 growing with a CAGR of YY% during the forecast period 2024-2031.
Glass packaging is extensively used in the pharmaceutical industry due to its nonreactive nature and resistance to temperatures. The shelf life of the product and its safety are important in the pharmaceutical industry and hence glass packaging is always preferred to safeguard the contents from oxidation and other reactions to prevent cross-contamination.
Glass packaging enhances the storage time and delivery of drugs which maintains the efficiency of the drug after a few days without any harmful effects. Due to the increasing access to healthcare costs, the demand for generic medicines has increased drastically due to the low costs. hence, the generic drug manufacturers will rely on glass packaging companies for bulk production.
Market Scope
| Metrics | Details |
| CAGR | YY% |
| Size Available for Years | 2022-2031 |
| Forecast Period | 2024-2031 |
| Data Availability | Value (US$) |
| Segments Covered | Product, Drug Type, Application |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics
Growing Pharmaceutical Industry
The pharmaceutical sector is experiencing expansion due to causes including the rising prevalence of chronic diseases, an expanding senior population, increased healthcare expenditures by government entities worldwide, and significant initiatives to enhance the affordability of drugs. A May 2022 article indicates that US officials are prioritizing the affordability of prescription drugs since excessively high prices jeopardize consumer access to adequate care.
The expanding patient population and heightened demand for treatments and pharmaceuticals across diverse therapeutic areas globally are prompting major pharmaceutical companies to intensify their research and development efforts to enhance their portfolios and pipeline products. As of March 2022, Sanofi's R&D pipeline included 91 clinical-stage compounds across multiple therapeutic areas, including oncology, autoimmune disorders, and neurology, with 34 currently in phase III trials or pending approval.
The growing incidence and awareness of chronic diseases, together with accessible treatment choices, are prompting major market participants to intensify their efforts in developing and launching new pharmaceuticals for numerous rare conditions. The expansion of the industry necessitates packaging for treatments of both communicable and non-communicable diseases. Consequently, the need for glass packaging in pharmaceutical manufacturing is rising due to its ability to safeguard medications against damage, biological contamination, and external factors.
The increasing demand for injectable medications is driving the expansion of glass bottles in the pharmaceutical sector. The robust demand for cancer and other high-potency pharmaceuticals, including antibody conjugates and rapidly acting steroids, together the increase in per capita pharmaceutical expenditure, is anticipated to be the principal catalysts for growth.
Growing Use of Generic Drugs Among People
The increase in healthcare costs led to the increase in the production of generic drugs due to the lower cost. The demand for these drugs is increasing among people as access to healthcare becomes easy.
According to the US Food and Drug Administration, 9 out of 10 prescriptions filled are for generic drugs in the United States. This is because of the high costs associated with drugs. The increasing availability of generic drugs gives rise to competition in the industry. These budding generic drug manufacturers need assistance in packaging their products. Here comes the pharmaceutical glass packaging companies that provide glass vials, ampoules, syringes, etc for filling the generic drug product.
Governments of developing countries are focusing on the reduction of healthcare costs by boosting the production of generic drugs to keep up the demand for generic drugs in the industry which generics represent less than 2% of all healthcare spending worldwide that indicates the low cost of the medicines when compared to the prescription drugs.
High Logistics Cost
Plastic and other materials are easy to transport when compared to glass as they are more fragile. Glass packaging transportation is risky and requires special packaging which costs more than normal packaging. Glass is often heavier than plastic or metal hence, costs more for transport in supply chains. The low weight plastics are always preferred during transportation to cut costs but high-end biosimilars need very expensive glass packaging.
Market Segmentation
The pharmaceutical glass packaging is segmented based on product, drug type, application and region.
The Vials Segment Accounted for Approximately 45.5% of the Market Share
Vials are expected to hold the largest share in the market due to the rising demand for vaccines and other drugs. Parenteral route drugs are often packed in vials which are highly in demand due to its quick action on the target. Launch of the glass vials by glass packaging companies by collaborating with different pharmaceutical companies are driving the market. For instance, in March 2022, SGD Pharma launched ready-to-use sterile 100ml molded glass vials using SG EZ-fill packaging technology.
Furthermore, in July 2023, Corning Incorporated launched Corning Viridian Vials to expand its glass packaging portfolio. The new technology can improve filling-line efficiency by up to 50% while reducing vial-manufacturing carbon dioxide equivalent (CO2e) emissions by up to 30%.
In October 2023, West Pharmaceutical Services, Inc. collaborated with Corning Incorporated for the launch of the first product. The company holds the distribution rights for Corning Valor Glass vials.
Market Geographical Share
North America accounted for Approximately 41.6% of the Market Share in 2022
North America is expected to hold the largest market share due to an increase in demand for generics and total savings as of 2022. For instance, according to the Association for Accessible Medicines, 2023, generic and biosimilar drugs generate $408 billion in savings for America’s patients and health-care system, including employers and taxpayers in 2022.
More than 90 percent of prescriptions were filled in 2022 with generic or biosimilar medicines, but they accounted for less than 18 percent of total prescription drug spending and less than 2 percent of total U.S. healthcare spending. These biosimilars are often packed in glass bottles to prevent unwanted drug reactions.
The demand for glass packaging companies in North America keeps up with the demand of generic drugs sold in this region. The glass packaging which includes vials, ampoules, and syringes is in high demand after the pandemic hit the world due to the usage of vaccines and other drugs.
COVID-19 Impact Analysis
Covid 19 hurt the pharmaceutical glass packaging market due to the stoppage of services such as manufacturing and production which has led to a shortage of drugs and medicines. The workforce and infrastructure have been disrupted due to the increase in the contraction of infection and the implementation of lockdowns worldwide. The healthcare and pharmaceutical sectors were not stable during the peak of covid 19.
Key Developments
- In March 2023, Schott launched the production of amber pharma glass in India to meet the increasing demand for pharmaceutical glass bottles.
- In November 2023, SGD Pharma launched a new glass bottle in its NOVA range which approximately 20% reduction in CO2 emissions compared with the standard heavy glass bottles.
- In June 2023, Corning Incorporated launched a venture that includes the opening of new glass tubing facility to expand its glass packaging portfolio in India.
- In October 2023, SCHOTT AG launched FIOLAX Pro glass tubing with green energy and significantly reduced the Product Carbon Footprint (PCF).
Competitive Landscape
The major global players in the pharmaceutical glass packaging market include Gerresheimer AG, Stevanato Group., NIPRO Corporation., SGD SA., Alphial S.r.l., Bormioli Pharma S.p.A., Ardagh Group, Beatson Clark, Vitro SAB, Stoelzle Glass Group. among others.
Why Purchase the Report?
To visualize the global pharmaceutical glass packaging market based on product type, drug type, application and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of pharmaceutical glass packaging market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global pharmaceutical glass packaging market report would provide approximately 58 tables, 65 figures, and 195 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
